Navigation Links
Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2013
Date:1/23/2013

%14.4%Net earnings per share – basic

$

0.87$

0.80Net earnings  per share – diluted

$

0.86$

0.79Shares used in the calculation of net earnings per share: Average shares outstanding - basic109.3112.3Average shares outstanding - diluted111.1114.4Varian Medical Systems, Inc. and SubsidiariesCondensed Consolidated Balance Sheets(In thousands)December 28,  September 28,20122012 (1)(Unaudited)AssetsCurrent assetsCash and cash equivalents

$

755,489

$

704,570Short-term investment 51,80449,709Accounts receivable, net637,473691,806Inventories499,616457,869Deferred tax assets and other283,931266,561Total current assets2,228,3132,170,515Property, plant and equipment669,119653,424Accumulated depreciation and amortization(370,586)(356,832)Property, plant and equipment, net298,533296,592Goodwill223,914222,242Other assets187,804189,377Total assets$

2,938,564

$

2,878,726Liabilities and Stockholders' EquityCurrent liabilitiesAccounts payable$

145,172

$

180,736Accrued expenses306,785336,568Deferred revenues132,881130,883Advance payments from customers396,229380,545Product warranty50,70552,799Short-term borrowings200,000155,000Total current liabilities1,231,7721,236,531Other long-term liabilities123,654126,169Long-term debt6,2506,250Total liabilities1,361,6761,368,950Stockholders' EquityCommon stock 109,322109,407Capital in excess of par value 609,246563,875Retained earnings and accumulated other comprehensive loss  858,320836,494Total stockholders' equity1,576,8881,509,776Total liabilities and stockholders' equity$

2,938,564

$

2,878,726(1)  The condensed consolidated balance sheet as of September 28, 2012 was derived from audited financial statements as of that date. 

FOR INFORMATION CONTACT:Elisha Finney (650) 424-6803

SOURCE Varian Medical Systems
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
2. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
3. Varian Medical Systems to Showcase Radiosurgery Technology for Non-invasive Treatment of Early Stage Inoperable Lung Cancer
4. U.S. Government Supports Phase 3 Study of Bavarian Nordics Smallpox Vaccine
5. Varian X-Ray Products Business Launches On-Line Product Finder for Customers
6. Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020
7. Cerulean Announces First Patient Dosed in Phase 2 Study of CRLX101 in Ovarian Cancer
8. Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2012
9. Researchers Discover All-Natural Weapon In The War Against Ovarian Cancer
10. Varian Medical Systems CEO Timothy E. Guertin Announces Plans to Retire; Board of Directors Names Dow R. Wilson as Successor
11. Varian Medical Systems Board of Directors Authorizes Repurchase of Additional 8 Million Shares of Stock through Calendar Year 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... June 29, 2015 Research ... the "Pharmaceutical Grade Sodium Chloride Market by Applications, ... report to their offering. The pharmaceutical ... CAGR of 6.9% between 2014 and 2019 in terms ... 690 KT by 2019. The report on ...
(Date:7/6/2015)... , July 6, 2015 Array ... was showcased this past weekend at the 2015 ... oral presentation.  At the meeting, data were shared ... from a 100-patient randomized Phase 2 expansion of ... cetuximab, an EGFR inhibitor, with or without the ...
(Date:7/6/2015)... July 6, 2015   Cepheid (Nasdaq: CPHD ... for its 2015 second quarter ended June 30, 2015 ... the market. The Company will host a ... July 23, 2015, to discuss the results.  To access ... http://ir.cepheid.com at least 15 minutes before the scheduled ...
Breaking Medicine Technology:Global Pharmaceutical Grade Sodium Chloride Market Report 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 4
... Confirm Robust Efficacy of CIMZIA, BOSTON, Nov. ... new,Phase III data from the RAPID 1 and ... Annual Scientific Meeting (ACR), which show,CIMZIA(R) (certolizumab pegol), ... Factor), given with methotrexate, is significantly,more effective than ...
... Fla., Nov. 7 A new analysis,presented today ... Evaluation Of Rosuvastatin) showed CRESTOR(R) (rosuvastatin calcium) 40,mg ... in four,patient populations at varying levels of risk ... subjects defined by the Framingham risk,assessment tool as ...
Cached Medicine Technology:CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 2CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 3CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 4CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 5CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 6CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 7CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year 8New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 2New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 3New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 4New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 5New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 6
(Date:7/4/2015)... NY (PRWEB) , ... July 04, 2015 , ... Chronic ... 15% of chronic pain sufferers have pain located in the neck. Another 19% suffer ... the neck. Chiropractic literature suggests that 45% of American workers must deal ...
(Date:7/4/2015)... ... 2015 , ... Tyler Boden, Project Developer of Sullivan Solar ... the North American Board of Certified Energy Practitioners (NABCEP®), and is now a ... well established national certification organization for renewable energy professionals. Designation as a NABCEP ...
(Date:7/3/2015)... ... July 03, 2015 , ... Brendon ... 2nd creating a buzz of media attention. In an effort to spread the ... Tiffany Hendricks. , "These days many people are feeling overwhelmed by stress and ...
(Date:7/3/2015)... ... July 03, 2015 , ... Rheumatology ... 2015 Annual Conference , the premiere continuing education and networking event for ... SeaWorld in Orlando, Florida. Speakers include the leading rheumatology experts in immunology, ...
(Date:7/3/2015)... ... July 03, 2015 , ... Renowned rhinoplasty surgeon and Symposium ... 2016 Dallas Rhinoplasty Symposium . To be held from March 4th - 6th, the ... at the Westin Galleria Dallas. , Designed to take participants from the basic training ...
Breaking Medicine News(10 mins):Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3
... Customer ... for engagement rings before meeting the partner they hope to marry - or any partner, for ... (PRWEB) May 8, 2010 ... a tendency among single women to shop for an engagement ring before actually finding ...
... of heart disease doubled for nurses with high work pressures, ... high-pressure job can boost the risk of heart disease among ... studies have mainly looked at high-pressure jobs and men, but ... part in the Danish Nurse Cohort Study. The women were ...
... ... Fastrack is the leading supplier of software & ... Infusion Pharmacies & Home Health Care Agencies. Only Fastrack offers ... as one system encompassing virtually every clinical, operational and financial aspect ...
... ... Supply is participating in the effort to raise awareness of the serious and growing problem of ... ... almost 7 million children have asthma (Atlanta is ranked 47th among the 50 worst cities for ...
... ... focused on lapel pins, coins, key chains, medallions and other metal products. In addition to ... excellent resource for all things related to lapel pins, and an informal forum for discussions related ... (PRWEB) May ...
... , ... Communications, Inc. (AIM: FCOM) (the “Company”), a leading Midwest competitive local exchange carrier providing ... ... First Communications, Inc. (AIM: FCOM) (the “Company”), a leading Midwest competitive local exchange carrier ...
Cached Medicine News:Health News:Statistics Reveal Women Choose Engagement Rings Before Men 2Health News:Fastrack Acquires Prometheus Group Industry Leading HME Billing Service 2Health News:National Allergy Supply Celebrates Asthma Awareness Month 2Health News:Monterey Lapel Pin Company Continues Its Website Evolution 2Health News:Monterey Lapel Pin Company Continues Its Website Evolution 3Health News:First Communications, Inc. Announces Audited Results for the Year Ended December 31, 2009 2Health News:First Communications, Inc. Announces Audited Results for the Year Ended December 31, 2009 3Health News:First Communications, Inc. Announces Audited Results for the Year Ended December 31, 2009 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: